Get started
ZELIRA THERAPEUTICS LIMITEDZELIRA THERAPEUTICS LIMITEDZELIRA THERAPEUTICS LIMITED

ZELIRA THERAPEUTICS LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ZLD chart


Full chart

Key stats


Market capitalization
‪7.04 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.225 AUD
Net income (FY)
‪−36.57 M‬ AUD
Revenue (FY)
‪94.95 K‬ AUD
Shares float
‪10.84 M‬
Beta (1Y)
0.49

About ZELIRA THERAPEUTICS LIMITED


Sector
Health Technology
CEO
Oludare Odumosu
Headquarters
Perth
Website
zeliratx.com
Founded
2003
ISIN
AU000000ZLD1
FIGI
BBG000K4GYF0
Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The firm engages in the research and development of cannabinoid-based formulations for the treatment of a variety of medical conditions. It focuses on human clinical trial program and pre-clinical research program. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ZLD news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ZLD is 0.620 AUD — it has increased by 1.64% in the past 24 hours. Watch ZELIRA THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ZELIRA THERAPEUTICS LIMITED stocks are traded under the ticker ZLD.
ZLD stock has risen by 3.33% compared to the previous week, the month change is a −6.06% fall, over the last year ZELIRA THERAPEUTICS LIMITED has showed a −30.88% decrease.
ZLD reached its all-time high on May 5, 2008 with the price of 391.015 AUD, and its all-time low was 0.275 AUD and was reached on Jun 28, 2024. View more price dynamics on ZLD chart.
See other stocks reaching their highest and lowest prices.
ZLD stock is 13.71% volatile and has beta coefficient of 0.49. Track ZELIRA THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is ZELIRA THERAPEUTICS LIMITED there?
Yes, you can track ZELIRA THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
ZLD net income for the last half-year is ‪−2.43 M‬ AUD, while the previous report showed ‪−34.13 M‬ AUD of net income which accounts for 92.87% change. Track more ZELIRA THERAPEUTICS LIMITED financial stats to get the full picture.
No, ZLD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZELIRA THERAPEUTICS LIMITED EBITDA is ‪−5.69 M‬ AUD, and current EBITDA margin is ‪−6.00 K‬%. See more stats in ZELIRA THERAPEUTICS LIMITED financial statements.
Like other stocks, ZLD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZELIRA THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZELIRA THERAPEUTICS LIMITED technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZELIRA THERAPEUTICS LIMITED stock shows the sell signal. See more of ZELIRA THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.